Maynard Um
-
-
-
-
-
-
-
Needham stays Buy on Lucid Diagnostics Inc (LUCD) as EsoGuard volumes surge
-
-
-
-
-
-
-
Lucid Diagnostics reports real-world data from 12,000 esophageal tests
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Lucid Diagnostics Inc (LUCD)
-
-
-
-
-
-
-
Lucid Diagnostics Inc. (LUCD) Tops Q1 EPS by 3c
-
-
-
-
-
-
-
Lucid Diagnostics Inc (LUCD) PT Raised to $3 at Needham
-
-
-
-
-
-
-
Lucid Diagnostics Inc (LUCD): Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard in At-Risk Patients without Symptomatic GERD
-
-
-
-
-
-
-
Needham Reiterates Buy Rating on Lucid Diagnostics Inc (LUCD)
-
444,513 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

